Investigation Report on China’s Rosuvastatin Market, 2018-2022

Publisher Name :
Date: 29-Nov-2018
No. of pages: 30

Rosuvastatin was first developed by Japanese company Shionogi & Co., Ltd. in the late 1980s. In Jun. 1998, Shionogi & Co., Ltd. transferred the right to develop, market and sell Rosuvastatin worldwide to AstraZeneca. The development code of Rosuvastatin by AstraZeneca is ZD-4522. Rosuvastatin was first approved in the Netherlands on Nov. 7, 2002, approved by the Health Council of Canada in Feb. 2003, and by the FDA on Aug. 12, 2003. The trade name of AstraZeneca’s branded Rosuvastatin is Crestor.

After Rosuvastatin was launched, its sales value grew sharply. Rosuvastatin has become a key product of statins. In 2012, Rosuvastatin became the number one lipid-lowering drug in the world with a sales value of USD 6.2 billion.

With the improvement of living standards and the change in diet, from 1978 to 2018, Chinese people’s blood lipid levels kept rising, and the incidence of dyslipidemia increased significantly. The overall incidence of dyslipidemia in Chinese adults is up to about 40%. As dyslipidemia is a major cause of the development of coronary heart disease, strokes and other atherosclerotic lesions, active treatment of hyperlipidemia can reduce the incidence of these diseases. In China, Rosuvastatin is used to treat primary hypercholesterolemia (Type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (Type IIb) that cannot be properly controlled via diet control and non-drug treatments (e.g. sports therapy and weight loss). In the treatment of homozygous familial hypercholesterolemia, it complements the diet control and other lipid-lowering measures (such as LDL removal), or serves as an alternative when these measures do not work.

According to CRI, Rosuvastatin has been growing rapidly since it entered China, with its sales revenue increasing from less than CNY 2 million in 2007 to more than CNY 1.1 billion in 2017. At present, China’s Rosuvastatin market is dominated by IPR PHARMACEUTICALS INC. (ASTRAZENECA), Lunan Better Pharmaceutical Co., Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd., Zhejiang Jingxin Pharmaceutical Co., Ltd., etc. Pfizer has the largest market share by sales value which was about 67% in 2017.

It is expected that as more Chinese people suffer from hyperlipidemia, China’s Rosuvastatin market will continue to grow in the next few years.

Topics Covered:


  • Situation of hyperlipidemia in China

  • Market size of Rosuvastatin in China

  • Competitive landscape of China’s Rosuvastatin market

  • Prices of Rosuvastatin in China

  • Prospect of China’s Rosuvastatin market from 2018 to 2022

Investigation Report on China’s Rosuvastatin Market, 2018-2022

Table of Contents

1 Relevant Concepts of Rosuvastatin
1.1 Indications for Rosuvastatin
1.2 Development of Rosuvastatin in China
1.3 Patents and Government Approval on Rosuvastatin in China

2 Sales of Rosuvastatin in China, 2013-2017
2.1 Sales Value of Rosuvastatin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Rosuvastatin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Rosuvastatin by Dosage Form in China, 2013-2017
2.3.1 Tablets
2.3.2 Capsules

3 Analysis on Major Rosuvastatin Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Rosuvastatin Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 IPR PHARMACEUTICALS INC.(ASTRAZENECA)
3.2.1 Enterprise Profile
3.2.2 Sales of Rosuvastatin by IPR PHARMACEUTICALS INC.(ASTRAZENECA) in China
3.3 Lunan Better Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Rosuvastatin by Lunan Better Pharmaceutical Co., Ltd. in China
3.4 Zhejiang Jingxin Pharmaceutical Co., Ltd.
3.5 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
3.6 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd.

4 Prices of Rosuvastatin in China, 2017-2018
4.1 IPR PHARMACEUTICALS INC.(ASTRAZENECA)(Crestor)
4.2 Lunan Better Pharmaceutical Co., Ltd. (Ruizhi)
4.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. (Jingnuo)
4.4 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (Tuotuo)
4.5 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. (Shufutan)

5 Prospect of China’s Rosuvastatin Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

List of Charts

Chart Government Approval of Rosuvastatin in China
Chart Sales Value of Rosuvastatin in China, 2013-2017
Chart Sales Value of Rosuvastatin in Parts of China, 2013-2017
Chart Sales Volume of Rosuvastatin in China, 2013-2017
Chart Sales Volume of Rosuvastatin in Parts of China, 2013-2017
Chart Sales Value of Rosuvastatin Tablets in China, 2013-2017
Chart Sales Value of Rosuvastatin Capsules in China, 2013-2017
Chart Market Share of Top 5 Rosuvastatin Manufacturers by Sales Value, 2013-2017
Chart Market Share of Top 5 Rosuvastatin Manufacturers by Sales Volume, 2013-2017
Chart Sales Value of Rosuvastatin by IPR PHARMACEUTICALS INC.(ASTRAZENECA), 2013-2017
Chart Sales Volume of Rosuvastatin by IPR PHARMACEUTICALS INC.(ASTRAZENECA), 2013-2017
Chart Sales Value of Rosuvastatin by Lunan Better Pharmaceutical Co., Ltd., 2013-2017
Chart Sales Volume of Rosuvastatin by Lunan Better Pharmaceutical Co., Ltd., 2013-2017
Chart Sales Value of Rosuvastatin by Zhejiang Jingxin Pharmaceutical Co., Ltd., 2013-2017
Chart Sales Value of Rosuvastatin by Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., 2013-2017
Chart Prices of Rosuvastatin (Crestor) by IPR PHARMACEUTICALS INC.(ASTRAZENECA) in Parts of China, 2017-2018
Chart Prices of Rosuvastatin (Ruizhi) by Lunan Better Pharmaceutical Co., Ltd. in Parts of China, 2017-2018
Chart Prices of Rosuvastatin (Jingnuo) by Zhejiang Jingxin Pharmaceutical Co., Ltd. in Parts of China, 2017-2018
Chart Prices of Rosuvastatin (Tuotuo) by Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. in Parts of China, 2017-2018
Chart Prices of Rosuvastatin (Shufutan) by Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. in Parts of China, 2017-2018
Chart Forecast on Sales Value of Rosuvastatin in China, 2018-2022

  • Global Digoxin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......
  • Global Heart Failure Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......
  • Global Atorvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......
  • Global Rosuvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......
  • Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 133
    According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period. Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......
  • Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period. Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......
  • Cilostazol - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......
  • Rosuvastatin - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110
    Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well. The global Rosuvastatin market size is expected......
  • Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Congestive Heart Failure Drugs market: According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs